Enpro Inc. (NPO): 10-K filed February 21, 2025

AI analysis of the 10-K that Enpro Inc. filed with the U.S. SEC on February 21, 2025, grounded in the primary-source EDGAR filing.

• Goodwill Impairment Risk Persists: Alluxa acquisition continues underperforming with 2023 impairment already taken and material risk of further write-downs, signaling management's concerns about acquisition value realization.

• Integration Execution Risk Elevated: Company now managing dual integration efforts (Advanced Micro Instruments from Jan 2024 plus ongoing LeanTeq integration from 2022), creating meaningful operational execution risk.

• Operational Restructuring Underway: US operations consolidations and employee relocations indicate underlying operational challenges requiring cost rationalization, suggesting management is addressing profitability pressures.

• Cautious Management Tone: Neutral-to-cautious sentiment reflects management's measured outlook amid integration complexity and balance sheet concerns, warranting investor scrutiny on near-term execution.

Filing analysis — key questions

Answers are generated from this SEC filing and StockHuntr's analysis. Not investment advice.

What does Enpro Inc. (NPO)'s 10-K filed February 21, 2025 say?

Company Overview: Enpro Inc. (formerly Enpro Industries Inc.) is a manufacturer of gaskets, packaging and sealing devices, and rubber and plastic hose products, incorporated in North Carolina with headquarters in Charlotte, NC Fiscal Period Covered: Annual report for the full year ended December 31, 2024, filed on February 21, 2025 Financial Statements Included: The filing contains comprehensive…

Is NPO's 10-K bullish or bearish?

Our analysis rates this filing CAUTIOUS. EnPro Inc. presents an elevated concern profile driven by multiple material risks in an increasing trend. The company faces two high-severity risks (goodwill impairment and semiconductor cyclicality) that directly threaten earnings quality and revenue…

How concerning is NPO's latest 10-K?

Concern level: HIGH (6.8/10). Key factors: Two high-severity risks identified (severity 7/10): Goodwill impairment risk on Alluxa acquisition and semiconductor market cyclicality exposure; Overall risk trend is INCREASING with risk score of 6.8/10, indicating deteriorating risk profile; Prior goodwill impairment on Alluxa (2023) with continued monitoring suggests acquisition has underperformed…

What are the main risks flagged in NPO's 10-K?

Notable risk changes: Alluxa goodwill impairment previously taken in 2023 with continued risk of additional impairments - indicates acquisition has underperformed expectations and remains a balance sheet concern; Advanced Micro Instruments Inc. acquisition completed Jan 2024 adds integration execution risk on top of ongoing LeanTeq integration from Dec 2022; Restructuring activities underway in US operations with…

About this analysis

Primary source:
View this 10-K on SEC EDGAR
Additional data:
Yahoo Finance (market data)
Method:
StockHuntr analyzes filings with AI — see our methodology.
Analysis as of:
February 21, 2025
Published by:
StockHuntr

For research and education only. Nothing here is investment advice.

📄

Fetching Filing from SEC

Downloading filing HTML from SEC.gov...

15% Complete
1
Fetch filing from SEC
2
Parse document sections
3
Fetch prior filing
4
Analyze risk factors
5
Analyze management sentiment
6
Extract financial metrics
7
Compare to analyst consensus
8
Run ML prediction model
9
Finalize analysis

Note: Analysis typically takes 30-60 seconds. We're fetching real SEC filing data and running AI analysis on the actual content.